AbbVie | Capitale Di Prestito



Loan Capital Cambiamento Data
AbbVie USD 60.34B 1.83B 2024-12
Abbott USD 12.62B 200M 2024-12
ALKERMES USD 0 285.82M 2024-12
Amgen USD 56.55B 305M 2024-12
AstraZeneca USD 27.73B 2.29B 2024-12
Biogen USD 4.55B 1.4M 2024-12
BioMarin Pharmaceutical USD 595.89M 1.27M 2024-12
Bristol-Myers Squibb USD 47.6B 1.07B 2024-12
Eisai JPY 99.82B 9M 2024-12
Eli Lilly USD 28.53B 518.3M 2024-12
Gilead Sciences USD 24.9B 3.46B 2024-12
GlaxoSmithKline GBP 14.64B 1.39B 2024-12
J&J USD 30.65B 638M 2024-12
Medtronic USD 23.99B 622M 2025-01
Merck USD 34.46B 520M 2024-12
Neurocrine Biosciences USD 0 0 2024-12
Novartis USD 22.93B 2.41B 2024-12
Pacira USD 383.54M 2.35M 2024-12
Perrigo USD 3.58B 730.9M 2024-12
Pfizer USD 57.4B 597M 2024-12
Regeneron Pharmaceuticals USD 2.7B 720.4M 2024-12
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 12.5B 1.84B 2024-06
UCB EUR 2.82B 166M 2024-12
Ultragenyx Pharmaceutical USD 0 0 2024-12
United Therapeutics USD 0 0 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12
Zoetis USD 5.22B 1.35B 2024-12



AbbVie Capitale Di Prestito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.